The overall picture of identified disease mutations suggests the involvement of α2δ proteins in epilepsy (particularly α2δ-2 but also α2δ-1) and ASD (mainly α2δ-3 but also α2δ-1). The gene discussed is ATXN2L; the disease is epilepsy.